Conestoga Capital Advisors LLC Sells 2,265 Shares of Transcat, Inc. (NASDAQ:TRNS)

Conestoga Capital Advisors LLC reduced its stake in shares of Transcat, Inc. (NASDAQ:TRNS) by 0.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 904,926 shares of the scientific and technical instruments company’s stock after selling 2,265 shares during the period. Conestoga Capital Advisors LLC owned approximately 0.10% of Transcat worth $95,687,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of TRNS. Royce & Associates LP increased its position in shares of Transcat by 8.2% during the third quarter. Royce & Associates LP now owns 511,701 shares of the scientific and technical instruments company’s stock worth $61,798,000 after acquiring an additional 38,774 shares in the last quarter. Champlain Investment Partners LLC increased its holdings in Transcat by 22.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock worth $49,455,000 after purchasing an additional 74,169 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Transcat by 5.4% in the 3rd quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company’s stock valued at $26,269,000 after purchasing an additional 11,106 shares during the period. State Street Corp lifted its holdings in shares of Transcat by 8.1% in the third quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company’s stock valued at $25,027,000 after purchasing an additional 15,514 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC boosted its position in shares of Transcat by 28.8% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company’s stock worth $9,577,000 after buying an additional 17,743 shares during the period. Institutional investors own 98.34% of the company’s stock.

Wall Street Analysts Forecast Growth

TRNS has been the topic of several research reports. Craig Hallum boosted their target price on Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. Oppenheimer lowered shares of Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. HC Wainwright reduced their target price on shares of Transcat from $126.00 to $106.00 and set a “buy” rating for the company in a report on Wednesday, January 29th. Northland Securities reiterated a “market perform” rating and issued a $85.00 price target (down from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. Finally, StockNews.com upgraded shares of Transcat from a “sell” rating to a “hold” rating in a research note on Tuesday, January 28th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, Transcat presently has a consensus rating of “Hold” and a consensus price target of $111.50.

Transcat Trading Up 0.4 %

NASDAQ:TRNS opened at $77.02 on Monday. The firm has a fifty day simple moving average of $103.15 and a 200 day simple moving average of $113.80. Transcat, Inc. has a 1-year low of $73.37 and a 1-year high of $147.12. The stock has a market capitalization of $708.58 million, a PE ratio of 41.63 and a beta of 0.68.

Transcat (NASDAQ:TRNS) last released its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.43%. During the same quarter last year, the firm posted $0.56 EPS. On average, equities analysts predict that Transcat, Inc. will post 2.3 earnings per share for the current fiscal year.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.